SCHEMBL5753979

SCHEMBL5753979

[CH2]C(O)NC(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28757967 1.00 — —
SCHEMBL9286582 0.78 KDM4E (0.39) —
SCHEMBL8899967 0.78 — —
SCHEMBL9276885 0.75 — —
SCHEMBL1263303 0.75 — —
SCHEMBL12858796 0.73 KDM4E (0.41) —
SCHEMBL7815667 0.73 — —
SCHEMBL6661692 0.73 KDM4E (0.41) —
SCHEMBL15094372 0.73 — —
SCHEMBL82871 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102459166-B Azetidinyl diamides as monoacylglycerol lipase inhibitors JANSSEN PHARMACEUTICA NV 2015-03-25 — — CN claimed
CN-101124199-B 5-substituted-2-phenylamino-benzamides as MEK inhibiting substances CHUGAI PHARMACEUTICAL CO.,LTD. (JP) 2011-12-14 — — CN claimed
CN-101304978-A Quinazoline derivatives as multiplex inhibitors and process for their preparation HANMI PHARM IND CO LTD (KR) 2008-11-12 — — CN claimed
CN-101124199-A 5-substituted-2-phenylamino-benzamides as MEK inhibiting substances CHUGAI PHARMACEUTICAL CO LTD (JP) 2008-02-13 — — CN claimed
CN-1910135-A Amino alcohol derivatives and their activity as renin inhibitors SPEEDEL EXPERIMENTA AG (CH) 2007-02-07 — — CN claimed
CN-102459166-B Azetidinyl diamides as monoacylglycerol lipase inhibitors JANSSEN PHARMACEUTICA NV 2015-03-25 — — CN disclosed
CN-104011028-A N-SUBSTITUTED AMINOBENZOCYCLOHEPTENE, AMINOTETRALINE, AMINOINDANE AND PHENALKYLAMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY ABBVIE DEUTSCHLAND 2014-08-27 — — CN disclosed
CN-103889968-A Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy ABBOTT GMBH & AMP 2014-06-25 — — CN disclosed
CN-102083797-B Tetrahydroisoquinolines, pharmaceutical compositions containing them and their use in therapy ABBOTT GMBH & CO KG 2014-06-04 — — CN disclosed
CN-103517898-A Novel 3-hydroxyisothiazole 1-oxide derivatives MOCHIDA PHARM CO LTD 2014-01-15 — — CN disclosed
CN-101784533-B 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy ABBOTT GMBH & CO KG 2013-08-21 — — CN disclosed
CN-103237788-A Phenalkylamine derivatives, pharmaceutical compositions containing them and their use in therapy ABBVIE DEUTSCHLAND 2013-08-07 — — CN disclosed
WO-2005019172-A1 INDOL-2-AMIDES AS GLYCOGEN PHOSPHORYLASE INHIBITORS ASTRAZENECA AB (SE) 2005-03-03 — — WO disclosed
WO-2005018637-A1 HETEROCYCLIC AMIDE DERIVATIVES WHICH POSSESS GLYCOGEN PHOSPHORYLASE INHIBITORY ACTIVITY ASTRAZENECA AB (SE) 2005-03-03 — — WO disclosed
CN-1163475-C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors ��ʲ 2004-08-25 — — CN disclosed
CN-1160337-C Process for preparation of vinyl pyrimidine derivant - 2004-08-04 — — CN disclosed
CN-1107059-C Azole deriv. YAMANOUCHI PHARMA CO LTD (JP) 2003-04-30 — — CN disclosed
CN-1275566-A Process for preparation of vinyl pyrimidine derivant HOFFMANN LA ROCHE (CH) 2000-12-06 — — CN disclosed
CN-1261877-A 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors WARNER LAMBERT CO (US) 2000-08-02 — — CN disclosed
CN-1160397-A Azole deriv. YAMANOUCHI PHARMA CO LTD (JP) 1997-09-24 — — CN disclosed
Send feedback